NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Support for researchers proposing innovative biomedical research concepts with potential to make significant impact; encourages interdisciplinary approaches and applicants from diverse backgrounds.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: October 13, 2023 | October 11, 2024 | October 10, 2025
Funding Amounts: Up to $300,000 direct costs/year for up to 5 years; max $1.5M direct costs total.
Summary: Supports exceptionally creative early career investigators proposing high-impact, innovative research in areas relevant to NIAID's mission; clinical trials are not allowed.
Key Information: Only single PD/PI applications from ESI-eligible, non-independent or newly independent investigators are accepted.
Description
This opportunity from the National Institute of Allergy and Infectious Diseases (NIAID) supports postdoctoral researchers, individuals in non-independent positions, and newly independent Early Stage Investigators (ESIs) who demonstrate exceptional creativity and propose novel, original, and insightful research concepts. The goal is to fund projects with the potential to make a major impact, test scientific paradigms, or advance key concepts in broad and important problems in biomedical research relevant to NIAID. Projects that represent an unexpected convergence of disciplines, new scientific directions, or employ novel methodologies are encouraged. Clinical trials are not allowed under this funding opportunity.
